Neratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Breast Cancer and Inflammatory Breast Cancer Patients With Abnormal HER-family and c-Met Pathway Activity as Measured by the CELsignia Signaling Analysis Test
Severity is deterministic uncalibrated triage metadata, not validated review priority. Operation-level severity
is inferred from deterministic path rules. Rule matches shown per operation are approximate previews (they skip
the pipeline's suppression passes); the authoritative classification is the stored
event record.
{
"resetReasons": [
"The Time Frame appears inconsistent with information provided here or in other parts of the record."
]
}
Raw JSON Patch
[
{
"op": "replace",
"path": "/protocolSection/statusModule/lastUpdateSubmitDate",
"value": "2025-04-29"
},
{
"op": "replace",
"path": "/protocolSection/statusModule/lastUpdatePostDateStruct/date",
"value": "2025-05-01"
},
{
"op": "add",
"path": "/protocolSection/outcomesModule/secondaryOutcomes/1/reviewUnit",
"value": {
"resetReasons": [
"The Time Frame appears inconsistent with information provided here or in other parts of the record."
]
}
},
{
"op": "add",
"path": "/protocolSection/outcomesModule/secondaryOutcomes/2/reviewUnit",
"value": {
"resetReasons": [
"The Time Frame appears inconsistent with information provided here or in other parts of the record."
]
}
},
{
"op": "add",
"path": "/protocolSection/outcomesModule/secondaryOutcomes/3/reviewUnit",
"value": {
"resetReasons": [
"The Time Frame appears inconsistent with information provided here or in other parts of the record."
]
}
},
{
"op": "add",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/3/reviewUnit",
"value": {
"resetReasons": [
"The Time Frame appears inconsistent with information provided here or in other parts of the record."
]
}
},
{
"op": "add",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/4/reviewUnit",
"value": {
"resetReasons": [
"The Time Frame appears inconsistent with information provided here or in other parts of the record."
]
}
},
{
"op": "add",
"path": "/resultsSection/outcomeMeasuresModule/outcomeMeasures/5/reviewUnit",
"value": {
"resetReasons": [
"The Time Frame appears inconsistent with information provided here or in other parts of the record."
]
}
},
{
"op": "replace",
"path": "/resultsSection/adverseEventsModule/timeFrame",
"value": "From the initiation of the first protocol-specific intervention to 2 years following the last dose of the drug, up to 27 months."
},
{
"op": "remove",
"path": "/resultsSection/adverseEventsModule/reviewUnit"
},
{
"op": "replace",
"path": "/annotationSection/annotationModule/unpostedAnnotation/unpostedEvents/0/date",
"value": "2025-04-30"
}
]